| Product ID |
Product Name |
CAS# |
Purity |
| Y1242444 |
Z433927330 |
1005883-72-6 |
98% |
| Y3290397 |
T3-ATA (S-isomer) |
2438721-48-1 |
95% |
| Y1242373 |
ZINC13466751 |
117953-17-0 |
98% |
| Y3291937 |
MMV008138 |
1679333-73-3 |
99% |
| Y3103838 |
T6167923 |
2437475-16-4 |
99% |
| Y1242374 |
c-Fms-IN-10 |
1527517-50-5 |
98% |
| Y1242445 |
NF-56-EJ40 |
2380230-73-7 |
99% |
| Y1237907 |
SBI-425 |
1451272-71-1 |
98% |
| Y3291577 |
TMP778 |
1422053-04-0 |
99% |
| Y1242331 |
CP-409092 hydrochloride |
225240-86-8 |
99% |
| Y3151645 |
(-)-SHIN1 |
2444764-09-2 |
99% |
| Y3151665 |
BPN-15606 |
1914989-49-3 |
99% |
| Y1242375 |
Seltorexant hydrochloride |
1293284-49-7 |
99% |
| Y1242435 |
DB1976 dihydrochloride |
2369663-93-2 |
98% |
| Y1242377 |
HWL-088 |
2378617-96-8 |
98% |
| Y1237932 |
Mevalonic acid lithium salt |
2618458-93-6 |
98% |
| Y3151608 |
AHR antagonist 2 |
2338747-54-7 |
99% |
| Y1242378 |
Dopamine D2 receptor antagonist-1 |
1055411-77-2 |
99% |
| Y1242333 |
BI-9321 trihydrochloride |
2387510-87-2 |
98% |
| Y3285763 |
TTP-8307 |
950225-08-8 |
99% |
| Y3305564 |
5-Chloro-2-(difluoromethoxy)benzyl amine HCl |
1515924-94-3 |
95% |
| Y1242400 |
SGK1-IN-2 |
1426214-64-3 |
98% |
| Y1246839 |
EZ-482 |
1016456-76-0 |
98% |
| Y1242463 |
Macropa-NH2 diester |
2146091-22-5 |
98% |
| Y1242475 |
Mito-apocynin (C2) |
1254044-41-1 |
98% |
| Y3109600 |
2,3,4-trimethyl-1H-indol-5-amine |
1494187-48-2 |
95% |
| Y1242401 |
HTL14242 |
1644645-32-8 |
98% |
| Y3309417 |
PF-03463275 |
1173239-39-8 |
98.40% |
| Y1242402 |
Resveratrol analog 1 |
861446-16-4 |
98% |
| Y3107077 |
Rocagloic acid |
190385-15-0 |
96% |
| Y1343813 |
DS-1971a |
1450595-86-4 |
99% |
| Y1242394 |
A2ti-2 |
482646-13-9 |
98% |
| Y3286810 |
Ebopiprant |
2005486-31-5 |
98% |
| Y3110492 |
Kgp-IN-1 hydrochloride |
2097865-47-7 |
95% |
| Y3292752 |
CXCR2-IN-2 |
1838123-21-9 |
99% |
| Y3110498 |
4-ethynyl-2-methylthiophene |
1479991-56-4 |
95% |
| Y3298177 |
Azvudine hydrochloride |
1333126-31-0 |
95% |
| Y1242335 |
RORt inverse agonist 13 |
2170477-75-3 |
99% |
| Y1242336 |
ALK2-IN-4 succinate |
2416307-25-8 |
95% |
| Y3306432 |
7-Oxa-2-azaspiro[4.5]decan-3-one |
1487759-95-4 |
97% |
| Y1246804 |
N-phenyl-4-(pyridin-3-yl)aniline |
1448787-63-0 |
98% |
| Y1242984 |
4-bromo-9-methyl-9-phenyl-9H-fluorene |
1548450-59-4 |
95% |
| Y3110116 |
7-bromo-6-fluoroquinolin-4-ol |
1443378-59-3 |
97% |
| Y3263082 |
4-Chloro-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazin-2-amine |
1446507-68-1 |
95% |
| Y1247449 |
8-chloro-5-methoxyisoquinoline |
1421600-95-4 |
98% |
| Y1242985 |
MEISi-2 |
2250156-71-7 |
98% |
| Y1243017 |
A3334 |
854171-31-6 |
99% |
| Y1247418 |
ALC-0159 |
1849616-42-7 |
98% |
| Y1247451 |
RB-OPD |
1034863-51-8 |
95% |
| Y1247374 |
Sel-green |
1574299-37-8 |
98% |
| Y3290133 |
BODIPY-TS |
1808174-52-8 |
97% |
| Y3110162 |
(R)-M8891 |
2575547-29-2 |
98% |
| Y1251675 |
3,4,5-Trihydroxycinnamic acid decyl ester |
1770778-45-4 |
98% |
| Y1247375 |
yGsy2p-IN-H23 |
1269190-98-8 |
99% |
| Y3290636 |
PB1 |
188714-28-5 |
98% |
| Y1242986 |
KL044 |
1801856-93-8 |
99% |
| Y3298176 |
1a-Hydroxy-3-epi-vitamin D3 |
58028-00-5 |
99% |
| Y1251677 |
M4205 |
2590556-80-0 |
99% |
| Y1247420 |
IDT307 |
1141-41-9 |
99% |
| Y3295446 |
GPR30 agonist-1 |
415919-74-3 |
98% |
| Y3151436 |
VH032 |
1448188-62-2 |
98% |
| Y1251679 |
Alkyne tyramide |
1694495-59-4 |
99% |
| Y3288134 |
AP39 |
1429061-80-2 |
95% |
| Y3289955 |
KS15 |
1033781-20-2 |
99% |
| Y3293672 |
Legumain inhibitor 1 |
2361157-34-6 |
98% |
| Y3151453 |
2-(2-Chloro-5-hydroxyphenyl)aceticacid |
149029-87-8 |
95% |
| Y1247456 |
Trx-red |
2368978-96-3 |
96% |
| Y1243021 |
Teplinovivint |
1428064-91-8 |
99% |
| Y3291374 |
FGFR4-IN-5 |
1628793-01-0 |
98% |
| Y3294826 |
ABM-14 |
1973408-76-2 |
98% |
| Y1247392 |
KB02-COOH |
2375196-30-6 |
98% |
| Y3287777 |
(E)-Akt inhibitor-IV |
959841-49-7 |
99% |
| Y3110172 |
PF-06843195 |
2067281-51-8 |
99% |
| Y3294085 |
SAR502250 |
503860-57-9 |
99% |
| Y1251715 |
HKYellow-AM |
1448821-89-3 |
98% |
| Y1242988 |
TPC2-A1-N |
136186-07-7 |
99% |
| Y3291331 |
CBR-470-2 |
2416095-00-4 |
99% |
| Y1247357 |
GSK3182571 |
2135595-04-7 |
99% |
| Y1247457 |
Ensifentrine |
1884461-72-6 |
95% |
| Y3297715 |
BRD3731 |
2056262-07-6 |
98% |
| Y3110187 |
Golgicide A-1 |
1394285-49-4 |
99% |
| Y3305100 |
Syk-IN-1 |
1491150-77-6 |
99.18% |
| Y3294408 |
(R)-MLN-4760 |
305335-29-9 |
99% |
| Y3110228 |
UNC5293 |
2226789-82-6 |
99% |
| Y3110184 |
DS-7423 |
1222104-37-1 |
99% |
| Y1256247 |
AP-1/NF-B activation inhibitor 1 |
188936-12-1 |
99% |
| Y3190309 |
Enpatoran hydrochloride |
2101945-93-9 |
99% |
| Y1260535 |
CBP/p300 ligand 2 |
2484741-78-6 |
98% |
| Y1260511 |
Thalidomide-O-amido-C3-PEG3-C1-NH2 |
1799711-29-7 |
97% |
| Y1256088 |
(Rac)-MEM 1003 |
165187-25-7 |
99% |
| Y3293094 |
TSHR antagonist S37b |
2143452-22-4 |
99% |
| Y3293939 |
P11149 |
164724-79-2 |
99% |
| Y1260483 |
Palosuran hydrochloride |
2469274-58-4 |
98% |
| Y3287304 |
(-)-Zuonin A |
84709-25-1 |
99% |
| Y3306991 |
Fmoc-Ala-Glu-Asn-Lys-NH2 |
220701-06-4 |
99.62% |
| Y3257226 |
SLF TFA |
2378802-47-0 |
99% |
| Y1260484 |
CHIKV-IN-2 |
2361289-44-1 |
98% |
| Y1260485 |
GKT136901 hydrochloride |
1254507-01-1 |
98% |
| Y3106514 |
Posenacaftor sodium |
2095064-06-3 |
99% |
| Y3288388 |
KRAS G12D inhibitor 1 |
2621928-43-4 |
98% |